Copper Dyshomeostasis, Redox Buffering and Immune Aging Converge on Cuproptosis in Age-Related Diseases. [PDF]
Jin Y, Lu K, Yang Y.
europepmc +1 more source
Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity. [PDF]
Li C +5 more
europepmc +1 more source
Targeting copper death-related long non-coding RNAs: a novel strategy to overcome immunotherapy resistance in liver cancer. [PDF]
Sheng X +9 more
europepmc +1 more source
Microrobotic copper-rich electrochemical interfacing for targeted cancer theranostics in the gut. [PDF]
Byun J +13 more
europepmc +1 more source
Boosting Cuproptosis in Breast Cancer Therapy via Photodynamic Treatment With a New Liposome. [PDF]
Yu J +9 more
europepmc +1 more source
The <i>EZH2-NEAT1</i> epigenetic axis promotes cuproptosis sensitivity and modulates cancer cell migration in colorectal cancer. [PDF]
Li R +7 more
europepmc +1 more source
SLC31A1 knockdown mitigates post-MI heart failure via regulation of copper metabolism. [PDF]
Wei Q, Zhou H, Sun J, Qin L.
europepmc +1 more source
XN@CuO/HA nanobipyramids trigger FOXO1-GADD45G-mediated cuproptosis and synergy with anti-PD-1 for lung cancer therapy. [PDF]
Jiang R +11 more
europepmc +1 more source
Iron and Copper Homeostasis in Cardiometabolic Disease: Therapeutic Potential of Chelators. [PDF]
Lachowicz JI, Gać P.
europepmc +1 more source
Mechanisms and therapeutic strategies of copper homeostasis in the pathogenesis of sepsis-induced cardiomyopathy. [PDF]
Xie Z, Wang H, You B, Li M, Li D, Wu H.
europepmc +1 more source

